Filter results
Type
Audience
Last updated
Topics
-
Urogynaecological mesh devices (mid-urethral slings) – Prescribed List post-listing review
Our work5 July 2024 - We reviewed the comparative clinical and cost-effectiveness of mid-urethral slings (MUS) on the Prescribed List (PL).
-
ATAGI recommendations on first booster dose in adolescents aged 12-15 years
News and media8 June 2022 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a first booster dose in adolescents aged 12-15 years.
-
Dignity of risk – Introduction to aged care video
Resources › Videos10 June 2025 - This video explores dignity of risk which is another way of saying that a person has the right to live the life they choose, even if those choices may involve some risk.
-
ATAGI statement on use of COVID-19 vaccines in an outbreak setting
News and media13 July 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of COVID-19 vaccines in an outbreak setting.
-
Life Saving Drugs Program – Sebelipase alfa (Kanuma®) outcome statement
Resources › Publications11 June 2025 - Summary of the consideration of the application from Alexion Australia for the inclusion of sebelipase alfa (Kanuma®) on the LSDP for the treatment of infantile onset lysosomal acid lipase deficiency (LAL-D).
-
Recommendation 5.3 – Review and update of disability strategies and plans
Disability Royal Commission Progress Report 2025 › Volume 5 – Governing for inclusion27 November 2025 - Read progress on recommendation 5.3 of the Disability Royal Commission.
-
New aged care regulatory model – provider obligations and rules – Webinar
Resources › Webinars28 August 2025 - This webinar was for aged care providers. It covered rules and provider obligations under the new regulatory model.
-
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
News and media17 May 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.
-
Choosing private health insurance
Topics › Private health insurance › About private health insurance11 February 2020 - It's not always easy to choose private health insurance cover that suits you and your family. There are lots of options so it's a good idea to work out what you need. These questions can help you decide what policy is right for you.
-
Life Saving Drugs Program – Mucopolysaccharidosis type VI (MPS VI) – Guidelines
Resources › Publications11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type VI (MPS VI) under the Life Saving Drugs Program.